December 10, 2018
A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures
Read More
December 10, 2018
Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492
Read More
X